GASTRIC

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Synchronous Peritoneal Metastases: Multicenter Study of ‘Italian Peritoneal SurfaceMalignancies Oncoteam—S.I.C.O.'

Luigi Marano, MD, PhD, Daniele Marrelli, MD, Paolo Sammartino, MD, PhD, Daniele Biacchi, MD, PhD,Luigina Graziosi, MD, PhD, Elisabetta Marino, MD, Federico Coccolini, MD, Paola Fugazzola, MD, Mario Valle, MD, Orietta Federici, MD, Dario Baratti, MD, Marcello Deraco, MD, Andrea Di Giorgio, MD, Antonio Macrì, MD, Enrico Maria Pasqual, MD, Massimo Framarini, MD, PhD, Marco Vaira, MD, Franco Roviello, MD


A Phase II Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Gastric Cancer and Carcinomatosis or Positive Cytology

Brian Badgwell, MD, MS, Naruhiko Ikoma, MD, MS, Mariela Blum Murphy, MD, Xuemei Wang, MS,Jeannelyn Estrella, MD, Sinchita Roy-Chowdhuri, MD, PhD, Prajnan Das, MD, Bruce D. Minsky, MD,Elizabeth Lano, MD, Shumei Song, PhD, Paul Mansfield, MD, and Jaffer Ajani, MD


Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis

Pierre-Emmanuel Bonnot, MD; Guillaume Piessen, MD, PhD; Vahan Kepenekian, MD; Evelyne Decullier, PhD;Marc Pocard, MD, PhD; Bernard Meunier, PhD; Jean-Marc Bereder, MD; Karine Abboud, MD; Frederic Marchal, MD, PhD;François Quenet, MD; Diane Goere, MD, PhD; Simon Msika, MD, PhD; Catherine Arvieux, MD, PhD; Nicolas Pirro, MD, PhD;Romuald Wernert, MD; Patrick Rat, MD, PhD; Johan Gagniere, MD, PhD; Jeremie H. Lefevre, MD, PhD; Thomas Courvoisier, MD;Reza Kianmanesh, MD, PhD; Delphine Vaudoyer, MD; Michel Rivoire, MD, PhD; Pierre Meeus, MD;Guillaume Passot, MD, PhD and Olivier Glehen, MD, PhD


Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP)

Israel Manzanedo, MD, Fernando Pereira, MD, PhD, Cristina Rihuete Caro, MD, Estibalitz Perez-Viejo, MD, PhD, Angel Serrano, MD, PhD, Alberto Gutierrez Calvo, MD, Fernando M. Regueira, MD, Angela Casado-Adam, MD, Pedro A. Cascales-Campos, MD, PhD, Xabier Arteaga, MD, Alfonso Garcia-Fadrique, MD, Remedios Gomez Sanz, MD, Adela Lopez Garcia, MD, Gabriel Zozaya, MD,Alvaro Arjona, MD, and Jose Gil Martinez, MD


Intraoperative hyperthermic intraperitoneal chemotherapy as adjuvantchemotherapy for advanced gastric cancer patients with serosal invasion

Lung-Yun Kang, King-Tong Mok, Shiuh-Inn Liu, Cheng-Chong Tsai, Being-Whey Wang,I-Shu Chen, Yu-Chia Chen, Bo-Min Chang, Nan-Hua Chou


Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial

Xiao-Jun Yang, MD, Chao-Qun Huang, MD, Tao Suo, MD, Lie-Jun Mei, MD, Guo-Liang Yang, MD,Fu-Lin Cheng, MD, Yun-Feng Zhou, MD, PhD, Bin Xiong, MD, PhD, Yutaka Yonemura, MD, PhD,and Yan Li, MD, PhD


Peritoneal Carcinomatosis from Gastric Cancer: A Multi-Institutional Study of 159 Patients Treated by Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy

Olivier Glehen, MD, PhD, Franc ̧ois Noel Gilly, MD, PhD, Catherine Arvieux, MD, PhD, Eddy Cotte, MD,Florent Boutitie, Baudouin Mansvelt, MD, PhD, Jean Marc Bereder, MD, Gerard Lorimier, MD, Francois Quenet, MD, Dominique Elias, MD, PhD